Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - United States

United States

In 2024, the revenue in the Cold & Cough Remedies market market in the United States amounts to €10.38bn.
It is projected to have an annual growth rate of 4.75% (CAGR 2024-2029).
The United States holds the majority of the global revenue in this market, generating €10.38bn in 2024.
When considering the total population figures, the per person revenue in 2024 is €30.37.
With the rise in cold and flu cases in the United States, the demand for over-the-counter cold and cough remedies is experiencing a significant surge.

Key regions: Australia, Japan, India, Brazil, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Cold & Cough Remedies market in United States has been experiencing steady growth in recent years.

Customer preferences: Consumers in the United States have shown a strong preference for over-the-counter cold and cough remedies. This can be attributed to several factors, including the convenience of purchasing these products without a prescription, the lower cost compared to prescription medications, and the perception that over-the-counter remedies are effective in relieving symptoms. Additionally, consumers in the United States tend to value products that offer multiple benefits, such as those that provide relief from both cold and cough symptoms.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in the United States is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional medications. This trend is driven by a growing interest in holistic health and wellness, as well as a desire for products that are perceived as safer and gentler on the body. As a result, companies in the market are introducing new products that are formulated with natural ingredients and are free from artificial additives.Another trend in the market is the rising popularity of combination products. These products offer a combination of ingredients that target multiple symptoms, such as congestion, cough, and sore throat. Combination products provide convenience to consumers by addressing multiple symptoms with a single product, and they are often marketed as providing faster and more effective relief. This trend is driven by consumer demand for products that offer comprehensive symptom relief and reduce the need for multiple medications.

Local special circumstances: The United States has a well-developed healthcare system, with a strong emphasis on self-care and consumer empowerment. This has contributed to the popularity of over-the-counter cold and cough remedies, as consumers are encouraged to take charge of their own health and seek appropriate treatments for minor ailments. Additionally, the United States has a large and diverse population, which provides a significant customer base for cold and cough remedies. This diversity also creates opportunities for companies to develop products that cater to specific consumer needs and preferences.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in the United States can be attributed to several underlying macroeconomic factors. Firstly, the high prevalence of cold and cough illnesses in the country drives demand for remedies. The United States has a relatively cold climate in many regions, which increases the likelihood of individuals contracting cold and cough viruses. Additionally, the aging population in the United States is more susceptible to respiratory illnesses, leading to increased demand for remedies.Furthermore, the United States has a strong pharmaceutical industry and a well-established distribution network, which facilitates the availability and accessibility of cold and cough remedies. This enables consumers to easily purchase these products from a variety of retail outlets, including pharmacies, supermarkets, and online platforms. The competitive landscape in the market also contributes to its growth, as companies continually innovate and introduce new products to meet consumer demand.In conclusion, the Cold & Cough Remedies market in the United States is developing in response to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal products, and the popularity of combination products. Local special circumstances, such as the emphasis on self-care and the diverse population, further contribute to the growth of the market. Underlying macroeconomic factors, including the high prevalence of cold and cough illnesses and the strong pharmaceutical industry, also play a significant role in the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.